Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14125030 | 1.00 | HDAC6 (0.35) | HDAC6CA14HDAC1HDAC2CTSK | |
| SCHEMBL2389721 | 0.87 | HDAC6 (0.35) | HDAC6HDAC1HDAC2CTSK | |
| SCHEMBL5018792 | 0.87 | HDAC6 (0.35) | HDAC6HDAC1HDAC2CTSK | |
| SCHEMBL14783864 | 0.87 | HDAC6 (0.35) | HDAC6HDAC1HDAC2CTSK | |
| SCHEMBL2748273 | 0.87 | HDAC6 (0.35) | HDAC6HDAC1HDAC2CTSK | |
| SCHEMBL28381761 | 0.84 | HDAC6 (0.33) | HDAC6CA14CTSK | |
| SCHEMBL16083949 | 0.84 | HDAC6 (0.33) | HDAC6CA14CTSK | |
| SCHEMBL15405615 | 0.83 | HDAC6 (0.35) | HDAC6HDAC1HDAC2CTSK | |
| SCHEMBL20342096 | 0.83 | TSHR (0.34) | HDAC6 | |
| SCHEMBL23407720 | 0.82 | MEN1 (0.34) | HDAC6CA14CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8784774-B2 | Labeled molecular imaging agents and methods of use | GENERAL ELECTRIC COMPANY (US) | 2014-07-22 | — | — | US | disclosed |
| US-20130071332-A1 | LABELED MOLECULAR IMAGING AGENTS AND METHODS OF USE | GENERAL ELECTRIC COMPANY (US) | 2013-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130071332-A1 | LABELED MOLECULAR IMAGING AGENTS AND METHODS OF USE | SLC7A11, GLS, SLC3A2 | HDAC6 2893/4885CA14 579/4885HDAC1 4265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.